Francisco Oliveira - Feb 18, 2022 Form 3 Insider Report for Ikena Oncology, Inc. (IKNA)

Role
Principal Accounting Officer
Signature
/s/ Francisco Oliveira
Stock symbol
IKNA
Transactions as of
Feb 18, 2022
Transactions value $
$0
Form type
3
Date filed
2/24/2022, 03:54 PM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding IKNA Stock Option (Right to Buy) Feb 18, 2022 Common Stock 30.2K $4.15 Direct F1
holding IKNA Stock Option (Right to Buy) Feb 18, 2022 Common Stock 11.2K $7.87 Direct F2
holding IKNA Stock Option (Right to Buy) Feb 18, 2022 Common Stock 30.6K $11.45 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option vested and became exercisable on May 14, 2020, with the remainder vesting in thirty-six equal monthly installments thereafter.
F2 25% of the shares underlying this option vested and became exercisable on February 12, 2022, with the remainder vesting in thirty-six equal monthly installments thereafter.
F3 25% of the shares underlying this option shall vest and become exercisable on January 1, 2023, with the remainder vesting in thirty-six equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney